Showing results (131-140 of 155) with videos related to
Sort By:
Pageof 16
Neurology|January 1, 1985
Dopaminergic receptor sites in human brain: positron emission tomographyJ C Baron, D Comar, E Zarifian, et al.Psychopharmacology|January 1, 1983
3H-Rauwolscine binding in platelets from depressed patients and healthy volunteersC Pimoule, M S Briley, C Gay, et al.Presse Medicale (Paris, France : 1983)|June 22, 1985
[Study of the metabolism of cerebral noradrenaline in depressed patients by the assay of plasma dihydroxyphenylethylene glycol]H Loo, B Scatton, M F Poirier, et al.European Journal of Clinical Pharmacology|January 19, 2000
Drug extrapyramidal side effects. CYP2D6 genotypes and phenotypesP Vandel, E Haffen, S Vandel, et al.Acta Psychiatrica Scandinavica|February 1, 1990
Diagnostic and therapeutic value of testing stimulation of thyroid-stimulating hormone by thyrotropin-releasing hormone in 100 depressed patientsJ M Vanelle, M F Poirier, C Benkelfat, et al.Neurophysiologie Clinique = Clinical Neurophysiology|August 1, 1988
[Caffeine and EEG mapping: effects of visuo-spatial task in healthy volunteers]P Etevenon, P Peron-Magnan, S Guillou, et al.Annals of Tropical Medicine and Parasitology|January 1, 1997
The chemotherapy of rodent malaria. LIII. 'Fenozan B07' (Fenozan-50F), a difluorinated 3,3'-spirocyclopentane 1,2,4-trioxane: comparison with some compounds of the artemisinin seriesS L Fleck, B L Robinson, W Peters, et al.The Journal of Laboratory and Clinical Medicine|November 1, 1990
Conjugated catecholamines in human plasma: where are they coming from?J L Cuche, P Brochier, N Klioua, et al.Annales De Medecine Interne|January 1, 1986
[Cerebral noradrenaline metabolism and classification of depression]H Lôo, M F Poirier, C Benkelfat, et al.Biological Psychiatry|August 1, 1986
Lack of correlation between plasma DOPEG and urinary MOPEG levels in depressed patientsH Lôo, T Dennis, J M Vanelle, et al.Pageof 16